featured
6-Month vs 12-Month Capecitabine as Adjuvant Chemotherapy for Patients With Stage III Colon Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase III Randomised Trial Comparing 6 vs. 12-Month of Capecitabine as Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Final Results of the JFMC37-0801 Study
Br. J. Cancer 2019 Mar 05;[EPub Ahead of Print], N Tomita, K Kunieda, A Maeda, C Hamada, T Yamanaka, T Sato, K Yoshida, N Boku, R Nezu, S Yamaguchi, H Mishima, S Sadahiro, K Muro, M Ishiguro, J Sakamoto, S Saji, Y MaeharaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.